
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145778110.1021/acsomega.7b00965ArticleLewis-Acid-Mediated Benzotriazole
Ring Cleavage (BtRC) Strategy
for the Synthesis of 2-Aryl Benzoxazoles from N-Acylbenzotriazoles† Singh Anoop
S. Mishra Nidhi Kumar Dhananjay ‡Tiwari Vinod K. *Department of Chemistry,
Institute of Science, Banaras Hindu University, Varanasi, U.P. 221005, India* E-mail: tiwari_chem@yahoo.co.in, vtiwari@ucdavis.edu. Fax: (+91) 542-236817.28 08 2017 31 08 2017 2 8 5044 5051 10 07 2017 14 08 2017 Copyright © 2017 American Chemical
Society2017American Chemical
SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A Lewis-acid-mediated ring cleavage
of acylbenzotriazoles (RCOBt)
followed by cyclization to corresponding benzoxazoles was achieved
in good to excellent yields. The reaction was found consistent with
the milligram to gram scale.

document-id-old-9ao7b00965document-id-new-14ao-2017-009652ccc-price
==== Body
Introduction
Benzotriazole methodology
has been emerged as an efficient, economical,
and quick way for common organic transformations during the last four
decades.1 The benzotriazole ring cleavage
(BtRC) approach proficiently assists the development of a wide spectrum
of benzoheterocycles via either Dimroth rearrangement, reagent-supported
ring opening, free radical path, photolysis, or thermolysis.2−6 Because of benzoxazole being one of the most fascinating moieties
having an extensive range of biological, pharmaceutical, industrial,
and analytical importance,7 we intended
to explore our standard protocols of benzotriazole methodology for
the synthesis of benzoxazole derivatives. Influenced by our previously
reported benzothiazole synthesis,2 which
followed free radical mechanism of BtRC, we applied a similar protocol
using tributyltin hydride for ring cleavage of N-phenylacylbenzotriazole.
However, the reaction resulted in N-phenylbenzamide8 instead of 2-phenyl benzoxazole. Then, we switched
our tryout from free-radical reagents to Lewis acid reagents and finally
became successful when we refluxed N-phenyl benzotriazole
with anhydrous AlCl3 in dry toluene (Scheme 1).

Scheme 1 Comparison of Benzotriazole Ring Cleavage
(BtRC) Processes
Results and Discussion
Our synthetic strategy was initiated
with the formation of N-acylbenzotriazoles (2) from corresponding
carboxylic acids (1) following two standard protocols,
i.e., either by reaction with thionyl chloride and 1H-benzotriazole or by treatment with PPh3/NBS and 1H-benzotriazole.4e,9 The resulting N-acylbenzotriazoles (2) were subjected to
ring cleavage by employing 1 equiv of anhydrous AlCl3 at
140 °C, which resulted in benzoxazole derivative 3 (Scheme 2).

Scheme 2 Synthesis
of Benzoxazole Derivative 3 from Corresponding N-Acylbenzotriazoles 2 through Cleavage of
Benzotriazole Ring
For the reaction optimization study, a sequence of reactions
were
carried out with compound 2a, in the presence of different
Lewis acids in various solvents at diverse ranges of temperature to
afford benzoxazole 3a (Table 1).

Table 1 Optimization with
(1H-Benzo[d][1,2,3]triazol-1-yl)(phenyl)methanone
entrya	reagent	amount (equiv)	time (h)	solvent	temp (°C)	yieldb (%)	
1	AlCl3	0.5	1	toluene	140	47	
2	AlCl3	0	4	toluene	140	0	
3	AlCl3	1	2	toluene	140	61	
4	AlCl3	1.2	2	toluene	140	65	
5	AlCl3	1.2	4	toluene	90	0	
6	AlCl3	1.2	4	toluene	110	0	
7	AlCl3	1.2	2	toluene	130	59	
8	AlCl3	1.2	2	toluene	150	63	
9	AlCl3	1.2	2	MeCN	45	0	
10	AlCl3	1.2	2	DMF	140	0	
11	AlCl3	1.2	2	DCM	45	0	
12	AlCl3	1.2	2	THF	45	0	
13	AlCl3	1.2	2	benzene	140	43	
14	ZnCl2	1.2	2	toluene	100	0	
15	ZnCl2	1.2	2	toluene	140	15	
16	CuCl2	1.2	2	toluene	140	0	
17	HgCl2	1.2	2	toluene	140	0	
18	FeCl3	1.2	2	toluene	140	53	
a Reaction carried
out at a higher
temperature in a sealed tube under argon.

b Yields reported after column chromatography
(SiO2).

Best
results were achieved with high-boiling-point, aprotic nonpolar
solvents, such as toluene and benzene. The optimum temperature for
the reaction was found to be 140 °C, and below 130 °C, the
reaction does not proceed at all. A total of 1.2 equiv of dry toluene
under inert atmospheric conditions yielded the maximum product (65%)
in 2 h. Among the various substrates, aryl-group-containing N-acylbenzotriazoles afforded benzoxazoles (Table 2), whereas alkyl-containing N-acylbenzotriazoles underwent traditional Friedel–Crafts
acylation.

Table 2 Synthesis of Benzoxazole Derivative 3a−s from Corresponding N-Acylbenzotriazoles 2a−sa,b
a Molar ratios: anhydrous
AlCl3 (1.2 equiv); yield reported after purification by
column
chromatography (SiO2).

b Yield of demethylated product 3h.

No specific variation of yield was
found with the electron-withdrawing-
or electron-donor-group substitution on the aryl ring. The substrate
containing iodo substituent at ortho postion 2q did not
give any product, and the starting compound was recovered after column
chromatography (SiO2). o-Methoxy-substituted
substrate 2f underwent demethylation and formed compound 3h (91%); however, the m-methoxy group did
not give such type of product, and target benzoxazole was isolated
in good yield. The optimized protocol successfully transformed various
acylbenzotriazoles 2a–s to their respective benzoxazoles 3a–s in good to excellent yields ranging from 43 to
91% (Table 2). However,
when we carried out this reaction with benzylic N-acylbenzotriazoles, we obtained corresponding ketones in excellent
yield, which suggests that the reaction followed the traditional Friedel–Crafts
path with alkyl substrates (Scheme 3).

Scheme 3 Formation of the Ketone Product from the Corresponding
Benzylic N-Acylbenzotriazole via the Traditional
Friedel–Crafts
Reaction
BtRC-Mediated Cyclization
Reaction on a Gram Scale
With the aim of performing quantity-based
generalization of the reaction,
we carried out the reaction with a larger quantity of starting materials.
Scaling up the quantity from a milligram to a gram scale did not affect
the course and yield of reaction, and the yields were found to be
64% and 81% for 3a and 3k, respectively
(Scheme 4).

Scheme 4 Synthesis
of Benzoxazole Derivatives 3a and 3n on
a Gram Scale via the BtRC Approach
The importance of developed benzoxazoles may be visualized
in terms
of its presence as a structural core in a diverse range of natural
and synthetic molecules, for example, antimycobacterial agents pseudopteroxazole,
UK-1, and AJI9561; HIV reverse transcriptase inhibitor L-697,661;
estrogen receptor-β agonist ERB-041; selective peroxisome proliferator-activated
receptor γ antagonist JTP-426467; anticancer agent NSC-693638;
and also Tafamidis meglumine, a transthyretin amyloid inhibitor (developed
by SCRIPPS/Pfizer in 2014) marketed for the treatment of neorodegenerative
disorder.7,10

Mechanistic Consideration
A plausible
mechanism of
the reaction is shown in Scheme 5, where AlCl3 initiates the process by a
rapid reaction with N-acylbenzotriazole to form intermediate A. This can give the traditional Friedel–Crafts product,
which is generally obtained in the case of aliphatic N-acylbenzotriazoles, but in the case of aryl N-acylbenzotriazole,
intermediate A favors cyclization via formation of carbocation
complex intermediates B and C with the loss
of molecular nitrogen (N2). The extended π-conjugative
interactions involved in the carbocation system develop its stability
and make the system stable enough to give the cyclized oxazole product.
The stabilization of intermediate C could be governed
via the delocalization of positive charge over the aryl ring and carbonyl
functionality (Scheme 5).

Scheme 5 Proposed Mechanism for Benzotriazole Ring Cleavage under Ionic
Conditions
Using Anhydrous AlCl3
Conclusions
In summary, we introduced a convenient
one-step synthetic route
to convert N-acylbenzotriazole to benzoxazole via
benzotriazole ring cleavage (BtRC). The reaction was best assisted
by AlCl3 and possibly followed a ionic mechanism. The synthetic
path showed equal compatibility with both electron-withdrawing and
electron-donating substituents on the aromatic ring as well as with
the quantity on a milligram or a gram scale.

Experimental Section
General
Remarks
All of the reactions were performed
under an argon atmosphere in anhydrous solvents. Glasswares were dried
in oven at 100 °C, 1 h prior to use. All reagents and solvents
were of pure analytical grade. Thin layer chromatography (TLC) was
carried out using 60 F254 silica gel-precoated aluminum
plates, and visualization was under a UV lamp (λmax = 254 nm). 1H and 13C NMR spectra were recorded
in CDCl3 solvent at 300 or 500 MHz and 75 or 125 MHz, respectively.
Chemical shifts are reported in parts per million downfield from TMS
as an internal standard; J values are reported in
hertz. Mass spectra were recorded using electrospray ionization mass
spectrometry (ESI-MS). IR spectra were recorded as Nujol mulls in
KBr pellets. Elemental analysis was performed by a C, H, N analyzer
with the results within ±0.4% of the calculated values.

Procedure
for the Synthesis of Arylcarbonylbenzotriazoles (RCOBt, 2a, 2c–2s) and Their Characterization
Data
To a solution of carboxylic acid (1a, 7.34
mmol) in anhydrous dichloromethane (100 mL), thionyl chloride (8.27
mmol) was added at room temperature and stirred for 15 min. 1H-1,2,3-Benzotriazole (25.69 mmol) was then added to this
mixture portionwise, and the resulting mixture was stirred for 2–3
h at room temperature. The completion of the reaction was monitored
by TLC, and the reaction mass was washed with 10% Na2CO3 solution, followed by water and brine solution. The organic
layer was separated, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The crude was purified
by flash column chromatography using ethyl acetate and n-hexane to afford pure products 2a.

Procedure for
the Synthesis of Arylcarbonylbenzotriazole (2b)
To a stirring solution of PPh3 (1.1
g, 4.41 mmol) and NBS (0.78 g, 4.41 mmol) in anhydrous dichloromethane
(25 mL), compound 1b (0.5 g, 3.67 mmol) was added at
0 °C and stirred for 15 min. To this mixture, 1H-benzotriazole (0.5 g, 4.2 mmol) was added portionwise, and the mixture
was allowed to stir at room temperature for 1 h. The completion of
the reaction was monitored by TLC, and the reaction mass was concentrated
under reduced pressure till dry. The crude was purified by flash column
chromatography using gradient mixtures of ethyl acetate and n-hexane to afford pure product 2b (0.84 g,
3.56 mmol).

(1H-Benzo[d][1,2,3]triazol-1-yl)(phenyl)methanone
(2a)11
White crystalline
solid, yield 95%; 1.55 g, Rf = 0.6 (10% ethyl acetate/n-hexane); mp =
112–113 °C; lit., mp 110–112 °C, MS: m/z 224 [M + H]; 1H NMR (300
MHz, CDCl3): δ 8.35 (d, J = 8.5
Hz, 1H), 8.20 (d, J = 7.5 Hz, 2H), 8.14 (d, J = 8.0 Hz, 1H), 7.68–7.65 (m, 2H), 7.56–7.49
(m, 3H); 13C NMR (75 MHz, CDCl3): δ 166.7,
145.7, 133.7, 132.3, 131.8, 131.5, 130.4, 128.5, 126.4, 120.2, and
114.8 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(p-tolyl)methanone (2b)11
White crystalline solid,
yield 97%; 0.84 g, Rf = 0.7 (10% ethyl acetate/n-hexane); mp = 123–124
°C; lit., mp 122–124 °C
MS: m/z 238 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.31 (d, J = 8.5 Hz, 1H), 8.10–8.08 (m, 3H), 7.63–7.60
(m, 1H), 7.46 (t, J = 7.5 Hz, 1H), 7.32 (d, J = 7.5 Hz, 2H), 2.42 (s, 3H); 13C NMR (75 MHz,
CDCl3): δ 166.5, 145.7, 144.8, 132.4, 132.0 (2C),
130.2, 129.2 (2C), 128.6, 126.2, 120.1, 114.8, and 21.8 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(m-tolyl)methanone (2c)11
White crystalline solid, yield 83%; 1.44 g, Rf = 0.8 (10% ethyl acetate/n-hexane); mp = 75–76 °C; lit., mp 77–79 °C
MS: m/z 238 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.31 (d, J = 8.5 Hz, 1H), 8.10 (d, J = 7.5 Hz, 1H),
7.96 (bs, 2H), 7.62 (t, J = 7.5 Hz, 1H), 7.49–7.40
(m, 3H), 2.41 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 166.9, 145.7, 138.3, 134.5, 132.4, 132.1, 131.4, 130.3,
129.0, 128.3, 126.3, 120.1, 114.8, and 21.4 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(o-tolyl)methanone (2d)11
White crystalline solid, yield 74%; 1.28 g, Rf = 0.8 (10% ethyl acetate/n-hexane); mp = 110–111 °C; lit., mp 110–111 °C
MS: m/z 238 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.27 (d, J = 8.5 Hz, 1H), 8.02 (d, J = 7.5 Hz, 1H),
7.58–7.55 (m, 1H), 7.51 (d, J = 6.5 Hz, 1H),
7.42–7.36 (m, 2H), 7.24–7.20 (m, 2H), 2.31 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 168.1, 145.9, 137.8,
132.1, 131.7, 131.5, 130.9, 130.2, 129.9, 126.2, 125.3, 120.1, 114.4,
and 19.9 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(3-methoxyphenyl)methanone
(2e)4f
White crystalline
solid, yield 72%; 1.34 g, Rf = 0.7 (10% ethyl acetate/n-hexane); mp =
80–84 °C; MS: m/z 254
[M + H]+; 1H NMR (300 MHz, CDCl3):
δ 8.35 (d, J = 7.5 Hz, 1H), 8.14 (d, J = 7.5 Hz, 1H), 7.79 (d, J = 7.5 Hz, 1H),
7.70–7.66 (m, 2H), 7.53–7.50 (m, 1H), 7.47–7.24
(m, 1H), 7.21–7.19 (m, 1H), 3.87 (s, 3H); 13C NMR
(75 MHz, CDCl3): δ 166.6, 159.5, 145.8, 132.6, 132.4,
130.4, 129.5, 126.4, 124.3, 120.3, 120.2, 116.2, 114.8, and 55.6 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(2-methoxyphenyl)methanone
(2f)11
Colorless
solid, yield 89%; 1.65 g, Rf = 0.6 (10% ethyl acetate/n-hexane); mp =
95–96 °C; lit., mp 96–97 °C MS: m/z 254 [M + H]+; 1H NMR (300
MHz, CDCl3): 1H NMR (300 MHz, CDCl3): δ 8.32 (d, J = 8.5 Hz, 1H), 8.05 (d, J = 7.5 Hz, 1H), 7.61–7.56 (m, 2H), 7.50–7.42
(m, 2H), 7.05–6.98 (m, 2H), 3.68 (s, 3H); 13C NMR
(75 MHz, CDCl3): δ 166.9, 157.9, 146.1, 133.6, 131.5,
130.4, 130.3, 126.2, 122.8, 120.5, 120.1, 114.4, 111.8, and 55.8 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(3-(trifluoromethyl)phenyl)methanone
(2i)4f
White crystalline
solid, yield 53%; 1.13 g, Rf = 0.7 (10% ethyl acetate/n-hexane); mp =
52–53 °C; lit., mp 52–54 °C MS: m/z 292 [M + H]+; 1H NMR (500
MHz, CDCl3): δ 8.47 (s, 1H), 8.42 (d, J = 7.5 Hz, 1H), 8.37 (d, J = 8.5 Hz, 1H), 8.16 (d, J = 8.5, 1H), 7.93 (d, J = 7.5 Hz, 1H),
7.72–7.69 (m, 2H), 7.55 (t, J = 7.5 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 165.4, 145.8,
134.9, 132.3, 132.2, 130.8, 130.2, 130.1, 129.1, 128.7, 128.6, 126.7,
120.4, and 114.8 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(3-fluorophenyl)methanone
(2j)4c
White crystalline
solid, yield 71%; 1.26 g, Rf = 0.6 (10% ethyl acetate/n-hexane); mp =
102–103 °C; lit., mp 102 °C MS: m/z 242 [M + H]+; 1H NMR (500
MHz, CDCl3): δ 8.34 (d, J = 8.5
Hz, 1H), 8.14 (d, J = 8.5 Hz, 1H), 8.03 (d, J = 7.5 Hz, 1H), 7.93 (d, J = 9.5 Hz, 1H),
7.68 (t, J = 7.5 Hz, 1H), 7.54 (dd, J = 7.5, 7.0 Hz, 2H), 7.38 (t, J = 7.5 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 165.3, 162.2 (d, J = 237.5 Hz), 145.7, 133.2 (d, J = 8.4
Hz), 132.2, 130.6, 130.1 (d, J = 8.4 Hz), 127.6 (d, J = 4.0 Hz), 126.5, 120.8 (d, J = 20 Hz),
120.3, 118.6 (d, J = 24 Hz), and 114.7 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(4-chlorophenyl)methanone
(2l)11
White crystalline
solid, yield 71%; 1.34 g, Rf = 0.5 (10% ethyl acetate/n-hexane); mp =
137–138 °C; lit., mp 138 °C MS: m/z 258 [M + H]+; 1H NMR (300
MHz, CDCl3): δ 8.30 (d, J = 8.5
Hz, 1H), 8.13–8.08 (m, 3H), 7.63 (t, J = 7.5
Hz, 1H), 7.49–7.46 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 165.6, 145.8, 140.5, 133.2 (2C), 132.3, 130.6,
129.8, 128.9 (2C), 126.6, 120.3, and 114.8 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(3-chlorophenyl)methanone
(2m)11
White crystalline
solid, yield 64%; 1.20 g, Rf = 0.5 (10% ethyl acetate/n-hexane); mp =
122–124 °C; lit., mp 120–121 °C MS: m/z 258 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.31 (d, J = 8.5 Hz, 1H), 8.15–8.06 (m, 3H), 7.67–7.60 (m, 2H),
7.52–7.45 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 165.3, 145.7, 134.6, 133.7, 133.1, 132.2, 131.6, 130.6,
129.9, 129.7, 126.6, 120.3, and 114.8.

(1H-Benzo[d][1,2,3]triazol-1-yl)(2-chlorophenyl)methanone
(2n)11
White crystalline
solid, yield 81%; 1.53g, Rf = 0.5 (15% ethyl acetate/n-hexane); mp =
81–83 °C; lit., mp 82–84 °C MS: m/z 258 [M + H]+; 1H NMR (300
MHz, CDCl3): δ 8.35 (d, J = 8.5
Hz, 1H), 8.09 (d, J = 7.5 Hz, 1H), 7.68–7.62
(m, 2H), 7.51–7.48 (m, 3H), 7.41–7.38 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 165.8, 146.2, 132.9,
132.7, 132.3, 131.3, 130.8, 130.2 (2C), 126.8, 126.7, 120.4, and 114.4
ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(4-bromophenyl)methanone
(2p)4g
Light yellow
solid, yield 83%; 1.83 g, Rf = 0.5 (10% ethyl acetate/n-hexane); mp =
130–132 °C; lit., mp 142–145 °C MS: m/z 302 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.23 (d, J = 8.5 Hz, 1H), 8.04 (d, J = 8.0 Hz, 1H), 8.00–7.97
(m, 2H), 7.60–7.56 (m, 3H), 7.44–7.41 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 165.5, 145.5, 133.0
(2C), 132.0, 131.6 (2C), 130.4, 130.0, 129.0, 126.4, 120.1, and 114.6
ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(2-bromophenyl)methanone
(2r)12,13
Solid, Rf = 0.7 (5% ethyl acetate/n-hexane); MS: m/z 302 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.35
(d, J = 8.4 Hz, 1H), 8.10 (d, J =
8.1 Hz, 1H), 7.70–7.60 (m, 3H), 7.53–7.38 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 166.0, 145.8, 134.7,
132.9, 132.3, 130.9, 130.4, 129.8, 127.0, 126.4, 120.2, 120.0, and
114.0 ppm.

(1H-Benzo[d][1,2,3]triazol-1-yl)(3-bromophenyl)methanone
(2s)14
Solid, yield
87%; 1.92 g, Rf = 0.7
(5% ethyl acetate/n-hexane); MS: m/z 302 [M + H]+; 1H NMR (300
MHz, CDCl3): δ 8.37(d, J = 9.0 Hz,
2H), 8.17 (d, J = 8.4 Hz, 2H), 7.81 (d, J = 8.1 Hz, 1H), 7.71 (t, J = 7.5 Hz, 1H), 7.58–7.53
(m, 1H), 7.45 (d, J = 7.8 Hz, 1H); anal. calcd for
C13H8BrN3O: C, 51.68; H, 2.67; N,
13.91. Found: C, 51.47; H, 2.71; N, 13.84.

Procedure for
the Synthesis of Benzoxazoles and Their Characterization
Data
A stirring solution of compound 2b (0.8
mmol) in toluene was added with AlCl3 (1 mmol) under an
inert atmosphere. The reaction was stirred under heating at 140 °C.
After the completion of the reaction (monitored by TLC), the reaction
mixture was concentrated in vacuo and extracted with CH2Cl2, water, and brine solutions. After drying over anhydrous
Na2SO4, the organic layer was concentrated in
vacuo. Purification using flash column chromatography afforded the
benzoxazole derivative.

2-Phenyl benzo[d]oxazole
(3a)15
Crystalline
solid, yield 65%; 0.101
g, Rf = 0.6 (2% ethyl
acetate/n-hexane); mp = 103–104 °C; lit.,
mp 102–104 °C MS: m/z 196 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.26 (dd, J = 3.9, 2.1 Hz, 2H), 7.79–7.76
(m, 1H), 7.60–7.53 (m, 4H), 7.35 (dd, J =
3.3,2.4 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ
163.0, 150.7, 142.0, 131.5, 128.8(2C), 127.5(2C), 127.1, 125.0, 124.5,
119.9, and 110.5 ppm.

2-(p-Tolyl)benzo[d]oxazole
(3b)15
White solid,
yield 59%; 0.98 g, Rf = 0.6 (2% ethyl acetate/n-hexane); mp = 116–118
°C; lit., mp 116–117 °C MS: m/z 210 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.12 (d, J = 8.1 Hz, 2H), 7.76–7.73
(m,1H), 7.55–7.52 (m, 1H), 7.32–7.27 (m, 4H), 2.40 (s,
3H); 13C NMR (75 MHz, CDCl3): δ 163.2,
150.7, 142.2, 142.0, 129.6 (2C), 127.5 (2C), 124.8, 124.4, 124.4,
119.8, 110.4, and 21.6 ppm.

2-(m-Tolyl)benzo[d]oxazole
(3c)15
Crystalline
solid, yield 61%; 0.102 g, Rf = 0.7 (2% ethyl acetate/n-hexane); mp = 84–86
°C; lit., mp 82–83 °C MS: m/z 210 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.00–7.94 (m, 2H), 7.68 (bs, 1H), 7.47 (bs,
1H), 7.33–7.16 (m, 4H), 2.35 (s, 3H); 13C NMR (75
MHz, CDCl3): δ 163.2, 150.7, 142.1, 138.6, 132.3,
128.7, 128.1, 127.0, 124.9, 124.7, 124.4, 119.8, 110.5, and 21.2 ppm.

2-(o-Tolyl)benzo[d]oxazole
(3d)15
Crystalline
solid, yield 60%; 0.100 g, Rf = 0.7 (2% ethyl acetate/n-hexane); mp = 67–68
°C; lit., mp 67 °C MS: m/z 210 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.16 (d, J = 7.5 Hz, 1H), 7.80–7.77
(m, 1H), 7.58–7.55 (dd, J = 3.3, 2.7 Hz, 1H),
7.41–7.26 (m, 5H), 2.80 (s, 3H); 13C NMR (75 MHz,
CDCl3): δ 163.3, 150.2, 142.1, 138.8, 131.7, 130.8,
129.8, 126.2, 125.9, 124.9, 124.3, 120.1, 110.4, and 22.1 ppm.

2-(3-Methoxyphenyl)benzo[d]oxazole (3e)16
Solid, yield 57%; 0.103 g, Rf = 0.6 (2% ethyl acetate/n-hexane);
mp = 72–74 °C; lit., mp 71–75
°C MS: m/z 226 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 7.85
(d, J = 7.8 Hz, 1H), 7.79–7.76 (m, 2H), 7.59
(dd, J = 3.3, 2.7 Hz, 1H), 7.42 (t, J = 7.8, 1H), 7.37–7.32 (m, 2H), 7.10–7.06 (m,1H), 3.91
(s, 3H); 13C NMR (75 MHz, CDCl3): δ 161.9,
158.9, 149.7, 141.0, 128.9, 127.3, 124.1, 123.5, 119.1, 119.0, 117.3,
110.9, 109.5, and 54.5 ppm.

2-(3-Phenoxyphenyl)benzo[d]oxazole (3g)17
Colorless crystalline solid,
yield 43%; 0.098 g, Rf = 0.6 (3% ethyl acetate/n-hexane); mp = 86–88
°C; lit., mp 84–86 °C MS: m/z 288 [M + H]+1H NMR (300 MHz, CDCl3): δ 7.97 (d, J = 7.8 Hz, 1H), 7.88
(s, 1H), 7.75–7.72 (m, 1H), 7.53–7.41 (m, 2H), 7.37–7.29
(m, 4H), 7.14–7.10 (m, 2H), 7.07–7.04 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 162.3, 157.8, 156.7,
150.7, 141.9, 130.3, 129.8(2C), 128.7, 125.2, 124.5, 123.7, 122.3,
121.8, 120.0, 119.1(2C), 117.5, and 110.6 ppm.

2-(Benzo[d]oxazol-2-yl)phenol (3h)18
Crystalline solid, yield
73%; 0.123 g, Rf = 0.5
(2% ethyl acetate/n-hexane); mp = 122–124
°C; lit., mp 123.5 °C MS: m/z 212 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 11.4 (s, 1H), 7.95 (d, J = 6.9 Hz,1H),
7.67–7.64 (m, 1H), 7.54–7.51 (m, 1H), 7.40–7.29
(m, 3H), 7.08 (d, J = 7.1 Hz, 1H), 6.95 (t, J = 7.5 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 162.7, 158.6, 148.9, 139.8, 133.4, 127.0, 125.2, 124.8,
119.4, 119.1, 117.2, 110.5, and 110.4 ppm.

2-(3-(Trifluoromethyl)phenyl)benzo[d]oxazole
(3i)19
Crystalline
solid, yield 67%; 0.14 g, Rf = 0.5 (3% ethyl acetate/n-hexane); mp = 119–122
°C; lit., mp 119–120 °C MS: m/z 264 [M + H]+1H NMR (300 MHz, CDCl3): δ 8.52 (s, 1H), 8.42 (d, J = 7.8
Hz,1H), 7.78–7.76 (m, 2H), 7.67–7.58 (m, 2H), 7.39–7.36
(m, 2H); 13C NMR (75 MHz, CDCl3): δ 161.4,
150.8, 141.8, 131.4, 130.5, 129.5, 128.0, 127.9, 125.7, 124.9, 124.5,
120.3, and 110.7; 19F NMR (470 MHz, CDCl3):
−62.77 ppm.

2-(3-Fluorophenyl)benzo[d]oxazole (3j)16
White solid, yield 69%; 0.117
g, Rf = 0.6 (3% ethyl
acetate/n-hexane); mp = 92–94 °C; lit.,
mp 92–94 °C MS: m/z 214
[M + H]+; 1H NMR (500 MHz, CDCl3):
δ 8.05 (d, J = 8.5 Hz, 1H), 7.96–7.93
(m, 1H), 7.79–7.75 (m, 1H), 7.60–7.58 (m, 1H), 7.52–7.47
(m, 1H), 7.39–7.36 (m, 2H), 7.25–7.21 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 163.9, 162.0, 161.8,
150.8, 142.0, 130.7, 130.6, 129.3, 129.2, 125.6, 124.8, 123.4, 123.3,
120.3, 118.6, 118.5, 114.7, 114.4, 110.7; 19F NMR (470
MHz, CDCl3): −111.6 ppm.

2-(3,5-Difluorophenyl)benzo[d]oxazole (3k)20
Yellow solid, yield
83%; 0.153 g, Rf = 0.6
(4% ethyl acetate/n-hexane); MS: m/z 232 [M + H]+1H NMR (300
MHz, CDCl3): δ 7.64–7.62 (m, 3H), 7.50–7.46
(m,1H), 7.32–7.28 (m, 2H), 6.90–6.84 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 164.9, 164.7, 161.6, 161.4,
160.7, 150.7, 141.7, 130.1, 129.9, 129.2, 125.8, 124.9, 120.4, 110.4
(m), 106.7 (m); 19F NMR (470 MHz, CDCl3): −107.9
ppm.

2-(4-Chlorophenyl)benzo[d]oxazole (3l)15
Colorless crystal solid,
yield 67%; 0.122 g Rf = 0.6 (2% ethyl acetate/n-hexane); mp = 150–151
°C; lit., mp 150 °C MS: m/z 230 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.16 (d, J = 8.4 Hz, 2H), 7.76–7.73
(m, 1H), 7.57–7.54 (m, 1H), 7.47 (d, J = 8.4
Hz, 2H), 7.37–7.33 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 162.0, 150.6, 141.9, 137.7, 129.2(2C), 128.7(2C),
125.6, 125.3, 124.7, 120.0, and 110.5 ppm.

2-(3-Chlorophenyl)benzo[d]oxazole (3m)16
Crystal solid, yield 57%;
0.104 g, Rf = 0.7 (3%
ethyl acetate/n-hexane); mp = 122–124 °C;
lit., mp 124–125 °C MS: m/z 230 [M + H]+; 1H NMR (500 MHz, CDCl3): δ 8.21 (s, 1H), 8.09 (d, J = 7.0 Hz, 1H),
7.76–7.74 (m, 1H), 7.56–7.54 (m, 1H), 7.47–7.35
(m, 2H), 7.34–7.33 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 161.6, 150.8, 141.9, 135.1, 131.5, 130.2, 128.9,
127.6, 125.7, 125.6, 124.8, 120.3, and 110.7 ppm.

2-(2-Chlorophenyl)benzo[d]oxazole (3n)21
Crystal solid, yield 77%;
0.141 g, Rf = 0.7 (3%
ethyl acetate/n-hexane); mp = 72–74 °C;
lit., mp 72 °C MS: m/z 230
[M + H]+; 1H NMR (300 MHz, CDCl3):
δ 8.15–8.12 (m, 1H), 7.86–7.83 (m, 1H), 7.61–7.53
(m, 2H), 7.44–7.36 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 160.8, 150.4, 141.6, 133.3, 131.8, 131.7, 131.3,
126.8, 126.1, 125.5, 124.5, 120.4, and 110.6 ppm.

2-(2,3-Dichlorophenyl)benzo[d]oxazole (3o)22
Crystal solid, yield
45%; 0.0942 g, Rf = 0.6
(3% ethyl acetate/n-hexane); mp = 88–90 °C;
lit., mp 90–92 °C MS: m/z 263 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.01 (d, J = 7.8, 1H), 7.85–7.82
(m, 1H), 7.62–7.60 (m, 2H), 7.42–7.30 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 160.2, 150.5, 141.4,
134.9, 132.6, 131.9, 130.0, 128.4, 127.2, 125.8, 124.7, 120.5, and
110.7 ppm; anal. calcd for C13H7Cl2NO: C, 59.12; H, 2.67; N, 5.30. Found: C, 59.37; H, 2.75; N, 5.21.

2-(4-Bromophenyl)benzo[d]oxazole (3p)22
White solid, yield 68%; 0.148
g, Rf = 0.6 (2% ethyl
acetate/n-hexane); mp = 158–160 °C; lit.,
mp 158–159 °C MS: m/z 274 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 8.11 (d, J = 8.4 Hz, 2H), 7.77–7.73
(m,1H), 7.65 (d, J = 8.4 Hz, 2H), 7.56–7.55
(m, 1H), 7.38–7.34 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 162.1, 150.7, 142.0, 132.2, 129.0, 126.2, 126.1,
125.3, 124.7, 120.1, and 110.6 ppm.

2-(2-Bromophenyl)benzo[d]oxazole (3r)22
White solid, yield 71%; 0.155
g, Rf = 0.6 (2% ethyl
acetate/n-hexane); mp = 52–54 °C; lit.,
mp 54–55 °C MS: m/z 274
[M + H]+; 1H NMR (300 MHz, CDCl3):
δ 8.06 (d, J = 6.9 Hz, 1H), 7.85–7.82
(m, 1H), 7.75 (d, J = 7.8 Hz, 1H), 7.61–7.58
(m, 1H), 7.45–7.30 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 161.4, 150.5, 141.5, 134.6, 132.0, 131.9, 128.3,
127.3, 125.4, 124.5, 121.8, 120.4, and 110.7 ppm.

2-(3-Bromophenyl)benzo[d]oxazole (3s)22
White solid, yield 63%; 0.137
g, Rf = 0.6 (2% ethyl
acetate/n-hexane); mp = 128–130 °C; lit.,
mp 136–138 °C MS: m/z 274 [M + H]+; 1H NMR (500 MHz, CDCl3): δ 8.40–8.39 (m, 1H), 8.16–8.15 (m, 1H), 7.77–7.75
(m,1H), 7.64–7.62 (m, 1H), 7.57–7.55 (m, 1H), 7.38–7.34
(m, 3H); 13C NMR (125 MHz, CDCl3): δ 161.5,
150.8, 141.9, 134.4, 130.5, 129.1, 126.1, 125.6, 124.8, 123.0, 120.3,
and 110.7 ppm.

2-(4-Chlorophenyl)-1-(p-tolyl)ethanone
(4)
White solid, yield 96%; Rf = 0.6 (1% ethyl acetate/n-hexane); mp = 108–110 °C; lit., mp 113 °C MS: m/z 245 [M + H]+; 1H NMR (300 MHz, CDCl3): δ 7.88 (d, J = 8.1 Hz, 2H), 7.27–7.15 (m, 6H), 4.20 (s, 2H), 2.38 (s,
3H); 13C NMR (75 MHz, CDCl3): δ 196.6,
144.1, 133.8, 133.1, 130.8, 129.3, 128.6, 128.5, 44.4, and 21.5 ppm.

Supporting Information Available
The
Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b00965.Typical experimental
procedure and characterization
data for acylbenzotriazoles and benzoxazoles, copies of 1H and 13C NMR spectra for all of the developed compounds,
and 19F NMR spectra of fluorinated compounds (PDF)



Supplementary Material
ao7b00965_si_001.pdf

 Author Present Address
‡ Department
of Chemistry, University of Delhi, New Delhi 110007,
India (D.K.).

The authors
declare no competing financial interest.

Acknowledgments
The authors
thank the Science Engineering and Research Board
(SERB), Department of Science & Technology, New Delhi (Grant No.
EMR/2016/001123) for the funding and CISC, Banaras Hindu University,
for providing spectroscopy studies.

† Manuscript Dedicated to (Late)
Prof. Alan R Katritzky for his excellent contributions to benzotriazole
chemistry.
==== Refs
References
a Katritzky A. R. ; Lan X. ; Yang J. Z. ; Denisko O. V. 
Properties
and Synthetic Utility of N-Substituted Benzotriazoles . Chem. Rev. 
1998 , 98 , 409 –548 . 10.1021/cr941170v .11848906  b Katritzky A. R. ; Rachwal S. 
Synthesis of Heterocycles Mediated
by Benzotriazole. 1. Monocyclic Systems . Chem.
Rev. 
2010 , 110 , 1564 –1610 . 10.1021/cr900204u .19799386  c Tiwari V. K. ; Mishra B. B. ; Mishra K. B. ; Mishra N. ; Singh A. S. ; Chen X. 
Cu-Catalyzed Click Reaction in Carbohydrate
Chemistry . Chem. Rev. 
2016 , 116 , 3086 –3240 . 10.1021/acs.chemrev.5b00408 .26796328  d Kale R. R. ; Prasad V. ; Mohapatra P. P. ; Tiwari V. K. 
Recent developments
in benzotriazole methodology for construction of pharmacologically
important heterocyclic skeletons . Monatsh. Chem. 
2010 , 141 , 1159 –1182 . 10.1007/s00706-010-0378-1 .
a Kumar D. ; Mishra A. ; Mishra B. B. ; Bhattacharya S. ; Tiwari V. K. 
Synthesis of Glycoconjugate Benzothiazoles
via Cleavage
of Benzotriazole Ring . J. Org. Chem. 
2013 , 78 , 899 –909 . 10.1021/jo3021049 .23270539  b Kumar D. ; Mishra B. B. ; Tiwari V. K. 
Synthesis of 2-N/S/C-Substituted Benzothiazoles
via Intramolecular Cyclative Cleavage of Benzotriazole Ring . J. Org. Chem. 
2014 , 79 , 251 –265 . 10.1021/jo4024107 .24313219 
Kumar D. ; Singh A. S. ; Tiwari V. K. 
An unprecedented
deoxygenation protocol
of benzylic alcohols using bis(1-benzotriazolyl)- methanethione . RSC Adv. 
2015 , 5 , 31584 –31593 . 10.1039/C5RA01545F .
a Katritzky A. R. ; Yang B. ; Jiang J. ; Steel P. J. 
Ring-Opening
Rearrangements of 2-(Benzotriazol-l-yl) Enamines and a Novel Synthesis
of 2,4-Diarylquinazoline . J. Org. Chem. 
1995 , 60 , 246 –249 . 10.1021/jo00106a041 . b Katritzky A. R. ; Zhang G. ; Jiang J. ; Steel P. J. 
A Novel o-Iminophenyl
Anion Route to Heterocycles and Ortho-Substituted Anilines . J. Org. Chem. 
1995 , 60 , 7625 –7630 . 10.1021/jo00128a040 . c Nakamura I. ; Nemoto T. ; Shiraiwa N. ; Terada M. 
Palladium-Catalyzed Indolization of N-Aroylbenzotriazoles with Disubstituted Alkynes . Org. Lett. 
2009 , 11 , 1055 –1058 . 10.1021/ol900113f .19243194  d Katritzky A. R. ; Huang T. B. ; Denisko O. V. ; Steel P. J. 
A Novel
Rearrangement to 1,2,4-Triazolo[1,5-a]quinoxalines . J. Org. Chem. 
2002 , 67 , 3118 –3119 . 10.1021/jo011028b .11975576  e Katritzky A.
R. ; Zhang Y. ; Singh S. K. 
Efficient Conversion of Carboxylic Acids into N-Acylbenzotriazoles . Synthesis 
2003 , 2795 –2798 . 10.1055/s-2003-42462 . f Kumar A. ; Ahmed Q. N. 
A Benzoquinone Imine Assisted Ring-Opening/Ring-Closing
Strategy of the RCOCHN1N2 System: Dinitrogen
Extrusion Reaction to Benzimidazoles . Eur. J.
Org. Chem. 
2017 , 2751 –2756 . 10.1002/ejoc.201700357 . g Singh A. S. ; Kumar D. ; Mishra N. ; Tiwari V. K. 
An efficient one-pot
synthesis of N,N′-disubstituted ureas and carbamates from N-acylbenzotriazoles . RSC Adv. 
2016 , 6 , 84512 –84522 . 10.1039/C6RA14131E . h Singh A. S. ; Singh M. ; Mishra N. ; Mishra S. ; Agrahari A. K. ; Tiwari V. K. 
N-Acylbenzotriazole as Efficient
Ligand in Copper-Catalyzed O-Arylation Leading to Diverse Benzoxazoles . ChemistrySelect 
2017 , 2 , 154 –159 . 10.1002/slct.201601116 .
a Micó X. À. ; Ziegler T. ; Subramanian L. R. 
A Versatile
Direct Approach to Ortho-Substituted Azobenzenes from Benzotriazoles . Angew. Chem., Int. Ed. 
2004 , 43 , 1400 –1403 . 10.1002/anie.200352782 . b Uhde M. ; Ziegler T. 
Reaction of N-Nitro-benzotriazole with Nucleophiles . Synth. Commun. 
2010 , 40 , 3046 –3057 . 10.1080/00397910903353754 . c Katritzky A. R. ; Ji F. B. ; Fan W. Q. ; Gallos J. K. ; Greenhill J. V. ; King R. W. ; Steel P. J. 
Novel Dimroth rearrangements of the
benzotriazole system: 4-amino-1-(arylsulfonyl)benzotriazoles to 4-[(arylsulfonyl)amino]benzotriazoles . J. Org. Chem. 
1992 , 57 , 190 –195 . 10.1021/jo00027a036 . d Habraken C. L. ; Erkelens C. ; Mellema J. R. ; Cohen-Fernandes P. 
1-Nitrobenzotriazole-2-(nitroimino)diazobenzene
isomerization: formation of triazenes by azo coupling with cyclic
amines. Structure determination and dynamic NMR . J. Org. Chem. 
1984 , 49 , 2197 –2200 . 10.1021/jo00186a024 . e Katritzky A. R. ; Akue-Gedu R. ; Vakulenko A. V. 
C-Cyanation with 1-cyanobenzotriazole . ARKIVOC 
2007 , iii , 5 –12 . 10.3998/ark.5550190.0008.302 . f Uhde M. ; Anwar M. U. ; Ziegler T. 
Reaction of N-nonaflyl and n-cyano-benzotriazoles with enamines . Synth. Commun. 
2008 , 38 , 881 –888 . 10.1080/00397910701845399 .
a Katritzky A. R. ; Yang B. ; Dalal N. S. 
Novel Heteroatom-Linked
Analogues of Trityl Radicals: Diaryl(benzotriazol-1-yl)methyl Radicals
Dimers . J. Org. Chem. 
1998 , 63 , 1467 –1472 . 10.1021/jo9715229 . b Kim T. ; Kim K. 
Practical method for synthesis of 2,3-disubstituted indole derivatives
promoted by β–(benzotriazol-1-yl)allylic O-stannyl ketyl
radicals . Tetrahedron Lett. 
2010 , 51 , 868 –871 . 10.1016/j.tetlet.2009.12.030 . c Katritzky A. R. ; Du W. ; Matskawa Y. ; Ghiviriga I. ; Denisenko S. N. 
Polycyclic
fused phenanthridines: An alternative approach from benzotriazoles . J. Heterocycl. Chem. 
1999 , 36 , 927 –932 . 10.1002/jhet.5570360417 .
a Rodríguez A. D. ; Ramirez C. ; Rodriguez I. I. ; Gonzalez E. 
Novel Antimycobacterial Benzoxazole Alkaloids, from
the West Indian Sea Whip Pseudopterogorgia elisabetha . Org. Lett. 
1999 , 1 , 527 –530 . 10.1021/ol9907116 .10822593  b Davidson J. P. ; Corey E. J. 
First Enantiospecific Total Synthesis of the Antitubercular
Marine Natural Product Pseudopteroxazole. Revision of Assigned Stereochemistry . J. Am. Chem. Soc. 
2003 , 125 , 13486 –13489 . 10.1021/ja0378916 .14583045  c Ueki M. ; Ueno K. ; Miyadoh S. ; Abe K. ; Shibata K. ; Taniguchi M. ; Oi S. 
UK-1, a novel cytotoxic
metabolite from Streptomyces sp. 517-02. I. Taxonomy, fermentation,
isolation, physico-chemical and biological properties . J. Antibiot. 
1993 , 46 , 1089 –1094 . 10.7164/antibiotics.46.1089 .8360104  d Sato S. ; Kajiura T. ; Noguchi M. ; Takehana K. ; Kobayashi T. ; Tsuji T. 
AJI9561, a new cytotoxic benzoxazole
derivative produced by Streptomyces sp . J. Antibiot. 
2001 , 54 , 102 –104 . 10.7164/antibiotics.54.102 .11269707  e Grobler J. A. ; Dornadula G. ; Rice M. R. ; Simcoe A. L. ; Hazuda D. J. ; Miller M. D. 
HIV-1 Reverse Transcriptase Plus-strand
Initiation Exhibits Preferential Sensitivity to Non-nucleoside Reverse
Transcriptase Inhibitors in Vitro . J. Biol. Chem. 
2007 , 282 , 8005 –8010 . 10.1074/jbc.M608274200 .17172472  f Leventhal L. ; Brandt M. R. ; Cummons T. A. ; Piesla M. J. ; Rogers K. E. ; Harris H. A. 
An estrogen receptor-β
agonist is active in models of inflammatory and chemical-induced pain . Eur. J. Pharmacol. 
2006 , 553 , 146 –148 . 10.1016/j.ejphar.2006.09.033 .17056036  g Nishiu J. ; Ito M. ; Ishida Y. ; Kakutani M. ; Shibata T. ; Matsushita M. ; Shindo M. 
JTP-426467 acts as
a selective antagonist for peroxisome proliferator-activated receptor
γ in vitro and in vivo . Diabetes, Obes.
Metab. 
2006 , 8 , 508 –516 . 10.1111/j.1463-1326.2005.00536.x .16918585  h Easmon J. ; Pürstinger G. ; Thies K.-S. ; Heinisch G. ; Hofmann J. 
Synthesis, Structure–Activity Relationships,
and Antitumor Studies of 2-Benzoxazolyl Hydrazones Derived from Alpha-(N)-acyl Heteroaromatics . J. Med. Chem. 
2006 , 49 , 6343 –6350 . 10.1021/jm060232u .17034140 
Singh A. S. ; Kumar D. ; Mishra N. ; Tiwari V. K. 
An Unprecedented
Synthesis of N-Phenyl Amides via Cleavage of Benzotriazole
Ring under Free Radical Condition . ChemistrySelect 
2017 , 2 , 224 –229 . 10.1002/slct.201601830 .
Singh A. S. ; Agrahari A. K. ; Singh M. ; Mishra N. ; Tiwari V. K. 
A new methodology
for the synthesis of N-acylbenzotriazoles . ARKIVOC 
2017 , v , 80 –88 .
a Bulawa C. E. ; Connelly S. ; DeVit M. ; Wang L. ; Weigel C. ; Fleming J. ; Packman J. ; Powers E. T. ; Wiseman R. L. ; Foss T. R. ; Wilson I. A. ; Kelly J. W. ; Labaudiniere R. 
Tafamidis, a potent and selective
transthyretin kinetic stabilizer that inhibits the amyloid cascade . Proc. Natl. Acad. Sci. U.S.A. 
2012 , 109 , 9629 –9634 . 10.1073/pnas.1121005109 .22645360  b Razavi H. ; Palaninathan S. K. ; Powers E. T. ; Wiseman R. L. ; Purkey H. E. ; Mohamadmohaideen N. N. ; Deechongkit S. ; Chiang K. P. ; Dendle M. T. A. ; Sacchettini J. C. ; Kelly J. W. 
Benzoxazoles as transthyretin amyloid fibril inhibitors:
Synthesis, evaluation, and mechanism of action . Angew. Chem., Int. Ed. 
2003 , 42 , 2758 –2761 . 10.1002/anie.200351179 .
Duangkamol C. ; Wangngae S. ; Pattarawarapan M. ; Phakhodee W. 
Acyloxyphosphonium
versus Aminophosphonium Intermediates: Application to the Synthesis
of N-Acylbenzotriazoles . Eur.
J. Org. Chem. 
2014 , 32 , 7109 –7112 . 10.1002/ejoc.201403076 .
Wet-osot S. ; Duangkamol C. ; Pattarawarapan M. ; Phakhodee W. 
Facile synthesis
of N-acylbenzotriazoles from carboxylic acids mediated
by 2,4,6-trichloro-1,3,5-triazine and triethylamine . Monatsh. Chem. 
2015 , 146 , 959 –963 . 10.1007/s00706-014-1408-1 .
Pramanik M. M. D. ; Rastogi N. 
Synthesis of α-diazo-β-keto
esters, phosphonates
and sulfones via acylbenzotriazole-mediated acylation of a diazomethyl
anion . Org. Biomol. Chem. 
2016 , 14 , 1239 –1243 . 10.1039/C5OB01975C .27186609 
Betori R. C. ; Miller E. R. ; Scheidt K. A. 
A Biocatalytic Route to Highly Enantioenriched
β-Hydroxydioxinones . Adv. Synth. Catal. 
2017 , 359 , 1131 –1137 . 10.1002/adsc.201700095 .29104524 
Wu F. ; Zhang J. ; Wei Q. ; Liu P. ; Xie J. ; Jiang H. ; Dai B. 
Copper-catalysed intramolecular O-arylation: a simple and efficient method for benzoxazole
synthesis . Org. Biomol. Chem. 
2014 , 12 , 9696 –9701 . 10.1039/C4OB02068E .25350639 
Leng Y. ; Yang F. ; Zhu W. ; Wu Y. ; Li X. 
Chlorination
and ortho-acetoxylation of 2-arylbenzoxazoles . Org. Biomol. Chem. 
2011 , 9 , 5288 –5296 . 10.1039/c1ob05223c .21647518 
Ueda S. ; Nagasawa H. 
Copper-Catalyzed Synthesis
of Benzoxazoles via a Regioselective C-H Functionalization/C-O Bond Formation
under an Air Atmosphere . J. Org. Chem. 
2009 , 74 , 4272 –4277 . 10.1021/jo900513z .19382756 
Banerjee S. ; Payra S. ; Saha A. ; Sereda G. 
ZnO nanoparticles:
a green efficient catalyst for the room temperature synthesis of biologically
active 2-aryl-1,3-benzothiazole and 1,3-benzoxazole derivatives . Tetrahedron Lett. 
2014 , 55 , 5515 –5520 . 10.1016/j.tetlet.2014.07.123 .
Yu X. ; Li X. ; Wan B. 
Palladium-catalyzed desulfitative arylation of azoles
with arylsulfonyl hydrazides . Org. Biomol. Chem. 
2012 , 10 , 7479 –7482 . 10.1039/c2ob26270c .22892562 
Chen T.-R. ; Lee H.-P. ; Chen J.-D. ; Chen K. H.-C. 
18+δ-iridium
dimer releasing metalloradicals spontaneously . Dalton Trans. 
2010 , 39 , 9458 –9461 . 10.1039/c0dt00605j .20820618 
Wang L. ; Ma Z.-G. ; Wei X.-J. ; Meng Q.-Y. ; Yang D.-T. ; Du S.-F. ; Chen Z.-F. ; Wu L.-Z. ; Liu Q. 
Synthesis
of 2-substituted pyrimidines and benzoxazoles via a visible-light-driven
organocatalytic aerobic oxidation: enhancement of the reaction rate
and selectivity by a base . Green Chem. 
2014 , 16 , 3752 –3757 . 10.1039/C4GC00337C .
Guru M. M. ; Ali M. A. ; Punniyamurthy T. 
Copper-Mediated Synthesis of Substituted
2-Aryl-N-benzylbenzimidazoles and 2-Arylbenzoxazoles
via C-H Functionalization/C-N/C-O Bond Formation . J. Org. Chem. 
2011 , 76 , 5295 –5308 . 10.1021/jo2005632 .21598946

